Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 1
1989 2
1990 3
1991 3
1992 6
1993 6
1994 3
1995 5
1996 13
1997 11
1998 8
1999 8
2000 4
2001 5
2002 12
2003 9
2004 9
2005 17
2006 5
2007 11
2008 3
2009 8
2010 14
2011 17
2012 15
2013 19
2014 9
2015 12
2016 13
2017 9
2018 6
2019 5
2020 6
2021 9
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

267 results
Results by year
Filters applied: . Clear all
Page 1
BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer.
Pilyugin M, Ratajska M, Stukan M, Concin N, Zeillinger R, Irminger-Finger I. Pilyugin M, et al. Among authors: zeillinger r. Genes (Basel). 2021 Jun 25;12(7):969. doi: 10.3390/genes12070969. Genes (Basel). 2021. PMID: 34201956 Free PMC article.
Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer.
Kasimir-Bauer S, Roder J, Obermayr E, Mahner S, Vergote I, Loverix L, Braicu E, Sehouli J, Concin N, Kimmig R, Net L, Roder H, Zeillinger R, Aust S, On Behalf Of The Ovcad Ovarian Cancer Diagnosis Initiative. Kasimir-Bauer S, et al. Among authors: zeillinger r. Cancers (Basel). 2020 Sep 4;12(9):2519. doi: 10.3390/cancers12092519. Cancers (Basel). 2020. PMID: 32899818 Free PMC article.
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.
Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF Jr, Taschner PE, Hainaut P, Soussi T. Leroy B, et al. Among authors: zeillinger r. Cancer Res. 2017 Mar 15;77(6):1250-1260. doi: 10.1158/0008-5472.CAN-16-2179. Cancer Res. 2017. PMID: 28254861 Free PMC article. Review.
Gene Expression of Kallikreins in Breast Cancer Cell Lines.
Watrowski R, Castillo-Tong DC, Obermayr E, Zeillinger R. Watrowski R, et al. Among authors: zeillinger r. Anticancer Res. 2020 May;40(5):2487-2495. doi: 10.21873/anticanres.14219. Anticancer Res. 2020. PMID: 32366393
Association of myeloperoxidase with ovarian cancer.
Castillo-Tong DC, Pils D, Heinze G, Braicu I, Sehouli J, Reinthaller A, Schuster E, Wolf A, Watrowski R, Maki RA, Zeillinger R, Reynolds WF. Castillo-Tong DC, et al. Among authors: zeillinger r. Tumour Biol. 2014 Jan;35(1):141-8. doi: 10.1007/s13277-013-1017-3. Epub 2013 Jul 27. Tumour Biol. 2014. PMID: 23893381 Free PMC article.
Patient satisfaction after breast cancer surgery : A prospective clinical trial.
Leser C, Tan YY, Singer C, Zeillinger R, Fitzal F, Lehrner J, König D, Deutschmann C, Gschwantler-Kaulich D. Leser C, et al. Among authors: zeillinger r. Wien Klin Wochenschr. 2021 Jan;133(1-2):6-13. doi: 10.1007/s00508-020-01730-w. Epub 2020 Sep 3. Wien Klin Wochenschr. 2021. PMID: 32880714 Free PMC article. Clinical Trial.
Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer.
Tserpeli V, Stergiopoulou D, Londra D, Giannopoulou L, Buderath P, Balgkouranidou I, Xenidis N, Grech C, Obermayr E, Zeillinger R, Pavlakis K, Rampias T, Kakolyris S, Kasimir-Bauer S, Lianidou ES. Tserpeli V, et al. Among authors: zeillinger r. Cancers (Basel). 2021 Dec 21;14(1):4. doi: 10.3390/cancers14010004. Cancers (Basel). 2021. PMID: 35008168 Free PMC article.
267 results